Merry Christmas.

2001-12-22 Thread bromideh

Season greetings and best wishes for a happy and prosperous new year.
Happy new year.

Sincerely yours,
Ali Bromideh

AALLLII
Statistician & Strategic 
Marketing Researcher,
Strategic Planning Center,
P.O.Box: 11365-1313,
Iran Khodro Co.,
Tehran, Iran.

Tel:0098-21-48902176
Fax:0098-21-48902332
E-mail: [EMAIL PROTECTED]


___
Never pay another Internet phone bill!
Freeserve AnyTime, for all the Internet access you want, day and night, only £12.99 
per month.
Sign-up at http://www.freeserve.com/time/anytime




=
Instructions for joining and leaving this list and remarks about
the problem of INAPPROPRIATE MESSAGES are available at
  http://jse.stat.ncsu.edu/
=



Re: Sr SAS Programmer Analyst - Regulatory Reporting - Job Posting - Bay

2001-12-22 Thread Vincent Granville

This is a multi-part message in MIME format.
--55B259120F859FCDB08EC5F7
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit

Vincent Granville, Ph.D.
Senior Statistician, Cnet
Founder, Data Shaping Solutions

Resume:
http://www.datashaping.com/vincent.shtml

--55B259120F859FCDB08EC5F7
Content-Type: application/msword;
 name="Resume.doc"
Content-Transfer-Encoding: base64
Content-Disposition: inline;
 filename="Resume.doc"

0M8R4KGxGuEAPgADAP7/CQAGAAABLgAA
EAAAMAEAAAD+AC0AAAD/







///spcEANyAJBAAA8BK/EAAABAAA
SQwAAA4AYmpialUWVRYJBBYAIhYAADd8AAA3fAAASQgA
AAD//w8AAAD//w8AAAD//w8A
AGwAACgBKAEAACgBKAEoAQAA
ACgBKAEAABQAADwBLAQsBCwE
LAQAAAw4BAAAFDwBsB0AAHgBAABYBFgE
WAQAAABYBFgEawUAAABrBQAAAGsFLx0AAAIA
AAAxHQAAADEdMR0xHQAAADEdMR0AACQoHwAA
IAIAAEghAABuVR0AABUAKAEAAABrBQAA
AABnBQAABGsFawUAAABrBQAAAFUd
ewcoAQAAACgBWAQAAFgEAAAPAQAAah0AABYA
AAB7BwAAAHsHewcAAABrBQAAmgAAACgBWAQoAQAA
AFgELx0AAHsH
awUvHQAAAHsHAACiAgAA
ewcdCgAAxgAAAHsbAACQKAEoAQAA
Lx0AAABYBAAA
AEwEAAAM4G+GswlAwQE8AQAA8AIAACwEBQYAABYLHAAAFAAA
Lx0AAACAHQAAMLAdHxwAABABAAC2IQAAABsGAABgAQAA
tiEvHQAAAHsHPAE8AQAAACgBKAEA
AAAoAQAAACgBAgDZMTAwMSBQYXJrdmlldyBEci4NUGl0dHNidXJnLCBD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Biostatistician, Job Posting, San Francisco, CA Biotech / Pharm "Regulatory Reporting"

2001-12-22 Thread Tom Whiting

Sr. Biostatistician – FDA Regulatory Reporting

Description: 

Work with senior biostatistics and clinical development teams to
design and conduct, evaluate, interpret and prepare results of
clinical studies. Develop methodolody for statistical analysis and
generate study randomization. Determine analysis and data presentation
specifications for programmer analysts and statisticians. Perform
analysis, interpret study results, collaborate with medical and
biostatistics staff to produce reports, and publications. Represent
the biostatistics function on project teams. Interact with FDA staff
to ensure drug studies meet FDA requirements. Attend meetings with FDA
on project development, collaborate with medical and biostatistics
staff to produce reports for the application to the FDA. This position
supports the development of various medical treatments.

Requirements: 
Minimum requirements: are a Ph.D. in Biostatistics or closely related
discipline and at least two years experience, or a Master's Degree in
Biostatistics and four years experience in the support of clinical
studies, preferably in a pharmaceutical industry or clinical studies
unit setting. Sol id experience in statistical experimental designs
and analyses, clinical trial requirements and statistical software
packages such as SAS and S-PLUS. Strong interpersonal and effective
communication (oral and written) skills. Pharmaceutical or closely
related industry experience. Experience with Phase I - III clinical
trials or studies in support of U.S. PLAs/NDAs

Email resume for immediate consideration, or for further information
please contact:

Tom Whiting
Enterprise Resource Group
San Francisco, CA
(voice) (415) 221-6300
(email) [EMAIL PROTECTED]


=
Instructions for joining and leaving this list and remarks about
the problem of INAPPROPRIATE MESSAGES are available at
  http://jse.stat.ncsu.edu/
=



Biostatistician, Job Posting, San Francisco, CA Biotech / Pharm "Clinical Studies"

2001-12-22 Thread Tom Whiting

Senior Biostatistician - Clinical Studies

Description: 

Be part of a successful and growing Biotech company developing new
generation drugs and medical treatments. Responsible for portions of
major clinical studies projects. This includes statistical integrity,
adequacy, and accuracy of clinical studies projects. Plan, coordinate,
and provides statistical analyses, summaries and reports for product
development and US PLAs/NDAs. Provides appropriate statistical advice
and support to the clinical directors. Adhere to standards of
acceptable statistical methodology, regulatory guidelines and
departmental guidelines.

Requirements: 

Ph.D. in Biostatistics or related discipline with 4 plus year’s
experience, or a Master's Degree in Biostatistics with 6 plus years
experience in the support of clinical studies, preferably in a
pharmaceutical industry or clinical studies setting. Knowledge of
applied statistics and biostatistics, and relevant experience in the
applications of statistics to medical trials. Experience with major
statistical software packages such as SAS and S-plus. Strong
interpersonal and effective communication (oral and written) skills.
Experience in phase I-III clinical trials or studies in support of
U.S. PLAs / NDAs.

Email resume for immediate consideration, or for further information
please contact:

Tom Whiting
Enterprise Resource Group
San Francisco, CA
(voice) (415) 221-6300
(email) [EMAIL PROTECTED]


=
Instructions for joining and leaving this list and remarks about
the problem of INAPPROPRIATE MESSAGES are available at
  http://jse.stat.ncsu.edu/
=



Is this how you would have done it?

2001-12-22 Thread Ralph Noble

How would you have done this?



A local newspaper asked its readers to rank the year's Top 10 news stories
by completing a ballot form. There were 10 choices on all but one ballot
(i.e. local news, sports news, business news, etc.), and you had to rank
those from 1 to 10 without duplicating any of your choices. One was their
top pick, 10 their lowest. Only one ballot had more than 10 choices, because
of the large number of local news stories you could choose from.



I would have thought if you only had 10 choices and had to rank from 1 to
10, then you'd count up all the stories that got the readers' Number One
vote and which ever story got the most Number One votes would have been
declared the winner.



Not so in the case of this newspaper . so maybe I do not understand
statistics. The newspaper told the readers there were several ways it could
have tallied the rankings. The newspaper decided to weight everybody's
responses and gave each first place vote a value of 10, each second place
nine, each third place eight, and so on. They then added together the values
for each story and then ranked the stories by point totals.



So is this an accurate way to have tallied the votes? And why weight them
since the pool in all but one category only had 10 items to choose from?



Thanks!



Ralph Noble

[EMAIL PROTECTED]







=
Instructions for joining and leaving this list and remarks about
the problem of INAPPROPRIATE MESSAGES are available at
  http://jse.stat.ncsu.edu/
=